Iranian Red Crescent Medical Journal

Published by: Kowsar

Emergence of blaOXA-Carrying Carbapenem Resistance in Multidrug-Resistant Acinetobacter baumannii in the Intensive Care Unit

Sareh Bagheri Josheghani 1 , Rezvan Moniri 1 , * , Farzaneh Firoozeh 1 , Mojtaba Sehat 2 , Kamran Dastehgoli 3 , Hasan Koosha 4 and Reza Khaltabadi Farahani 5
Authors Information
1 Department of Microbiology and Immunology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, IR Iran
2 Trauma Research Center, Kashan University of Medical Sciences, Kashan, IR Iran
3 Anatomical Sciences Research Center, Kashan University of Medical Sciences, Kashan, IR Iran
4 Shahid Beheshti Hospital, Kashan University of Medical Sciences, Kashan, IR Iran
5 National Center for Diagnosis, Reference Laboratory of Veterinary and Applied Studies, Tehran, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: May 2017, 19 (5); e27327
  • Published Online: June 13, 2016
  • Article Type: Research Article
  • Received: January 25, 2015
  • Accepted: February 7, 2015
  • DOI: 10.5812/ircmj.27327

To Cite: Bagheri Josheghani S, Moniri R, Firoozeh F, Sehat M, Dastehgoli K, et al. Emergence of blaOXA-Carrying Carbapenem Resistance in Multidrug-Resistant Acinetobacter baumannii in the Intensive Care Unit, Iran Red Crescent Med J. 2017 ; 19(5):e27327. doi: 10.5812/ircmj.27327.

Abstract
Copyright © 2016, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Gadani H, Vyas A, Kar AK. A study of ventilator-associated pneumonia: Incidence, outcome, risk factors and measures to be taken for prevention. Indian J Anaesth. 2010; 54(6): 535-40[DOI][PubMed]
  • 2. Lambiase A, Rossano F, Piazza O, Del Pezzo M, Catania MR, Tufano R. Typing of Pseudomonas aeruginosa isolated from patients with VAP in an intensive care unit. New Microbiol. 2009; 32(3): 277-83[PubMed]
  • 3. Bergmans DC, Bonten MJ, Gaillard CA, Paling JC, van der Geest S, van Tiel FH, et al. Prevention of ventilator-associated pneumonia by oral decontamination: a prospective, randomized, double-blind, placebo-controlled study. Am J Respir Crit Care Med. 2001; 164(3): 382-8[DOI][PubMed]
  • 4. Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection. 2005; 33(5-6): 309-13[DOI][PubMed]
  • 5. Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006; 27(4): 351-3[DOI][PubMed]
  • 6. Walther-Rasmussen J, Hoiby N. Class A carbapenemases. J Antimicrob Chemother. 2007; 60(3): 470-82[DOI][PubMed]
  • 7. Brown S, Amyes S. OXA (beta)-lactamases in Acinetobacter: the story so far. J Antimicrob Chemother. 2006; 57(1): 1-3[DOI][PubMed]
  • 8. Segal H, Garny S, Elisha BG. Is IS(ABA-1) customized for Acinetobacter? FEMS Microbiol Lett. 2005; 243(2): 425-9[DOI][PubMed]
  • 9. Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett. 2006; 258(1): 72-7[DOI][PubMed]
  • 10. Wroblewska MM, Towner KJ, Marchel H, Luczak M. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland. Clin Microbiol Infect. 2007; 13(5): 490-6[DOI][PubMed]
  • 11. Wikler MA. Performance standards for antimicrobial susceptibility testing: Twentieth informational supplement. 2013;
  • 12. Feizabadi MM, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M, et al. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn J Infect Dis. 2008; 61(4): 274-8[PubMed]
  • 13. Moniri R, Farahani RK, Shajari G, Shirazi MN, Ghasemi A. Molecular epidemiology of aminoglycosides resistance in acinetobacter spp. With emergence of multidrug-resistant strains. Iran J Public Health. 2010; 39(2): 63-8[PubMed]
  • 14. Safari M, Saidijam M, Bahador A, Jafari R, Alikhani MY. High prevalence of multidrug resistance and metallo-beta-lactamase (MbetaL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. J Res Health Sci. 2013; 13(2): 162-7[PubMed]
  • 15. Talebi TM, Latifnia M, Moosavai SAJ, Adabi M, Sh B. Risk factors and antimicrobial susceptibility in ventilator associated pneumonia: A brief report. Tehran Univ Med Scie. 2012; 70(9): 577-82
  • 16. Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, Najafi F. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol. 2013; 5(3): 195-202[PubMed]
  • 17. Amini M, Davati A, Golestanifard M. Frequency of nosocomial infections with antibiotic resistant strains of acinetobacterspp. In icu patient. Iranian J Pathol. 2012; 7(4): 241-5
  • 18. Japoni S, Farshad S, Abdi Ali A, Japoni A. Antibacterial susceptibility patterns and cross-resistance of acinetobacter, isolated from hospitalized patients, southern iran. Iran Red Crescent Med J. 2011; 13(11): 832-6[PubMed]
  • 19. Khosrishahi N, Sharifi M. Isolation of carbapenem resistant acinetobacter baumannii (crab) strains from patients and equipments of intensive care units (icus) at qazvin between 2005-2006. Iranian J Med Microbiol. 2007; 1(3): 33-8
  • 20. Karbasizade V, Heidari L. Antimicrobial resistance of acinetobacter baumannii isolated from intensive care units of isfahan hospitals, iran. J Isfahan Med Sch. 2012; 30(191)
  • 21. Al-Agamy MH, Khalaf NG, Tawfick MM, Shibl AM, El Kholy A. Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt. Int J Infect Dis. 2014; 22: 49-54[DOI][PubMed]
  • 22. Nwadike VU, Ojide CK, Kalu EI. Multidrug resistant acinetobacter infection and their antimicrobial susceptibility pattern in a nigerian tertiary hospital icu. Afr J Infect Dis. 2013; 8(1): 14-8[DOI]
  • 23. Al Johani SM, Akhter J, Balkhy H, El-Saed A, Younan M, Memish Z. Prevalence of antimicrobial resistance among gram-negative isolates in an adult intensive care unit at a tertiary care center in Saudi Arabia. Ann Saudi Med. 2010; 30(5): 364-9[DOI][PubMed]
  • 24. Zhou H, Pi BR, Yang Q, Yu YS, Chen YG, Li LJ, et al. Dissemination of imipenem-resistant Acinetobacter baumannii strains carrying the ISAba1 blaOXA-23 genes in a Chinese hospital. J Med Microbiol. 2007; 56: 1076-80[DOI][PubMed]
  • 25. Heritier C, Poirel L, Fournier PE, Claverie JM, Raoult D, Nordmann P. Characterization of the naturally occurring oxacillinase of Acinetobacter baumannii. Antimicrob Agents Chemother. 2005; 49(10): 4174-9[DOI][PubMed]
  • 26. Taherikalani M, Fatolahzadeh B, Emaneini M, Soroush S, Feizabadi MM. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol. 2009; 32(3): 265-71[PubMed]
  • 27. Brown S, Young HK, Amyes SG. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect. 2005; 11(1): 15-23[DOI][PubMed]
  • 28. Bali NK, Fomda BA, Bashir H, Zahoor D, Lone S, Koul PA. Emergence of carbapenem-resistant Acinetobacter in a temperate north Indian State. Br J Biomed Sci. 2013; 70(4): 156-60[PubMed]
  • 29. Dalla-Costa LM, Coelho JM, Souza HA, Castro ME, Stier CJ, Bragagnolo KL, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol. 2003; 41(7): 3403-6[PubMed]
  • 30. Poirel L, Marque S, Heritier C, Segonds C, Chabanon G, Nordmann P. OXA-58, a novel class D {beta}-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother. 2005; 49(1): 202-8[DOI][PubMed]
  • 31. Coelho J, Woodford N, Afzal-Shah M, Livermore D. Occurrence of OXA-58-like carbapenemases in Acinetobacter spp. collected over 10 years in three continents. Antimicrob Agents Chemother. 2006; 50(2): 756-8[DOI][PubMed]
  • 32. Castanheira M, Wanger A, Kruzel M, Deshpande LM, Jones RN. Emergence and clonal dissemination of OXA-24- and OXA-58-producing Acinetobacter baumannii strains in Houston, Texas: report from the SENTRY Antimicrobial Surveillance Program. J Clin Microbiol. 2008; 46(9): 3179-80[DOI][PubMed]
  • 33. Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother. 2009; 63(1): 55-9[DOI][PubMed]
  • 34. Nowak P, Paluchowska P, Budak A. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland. New Microbiol. 2012; 35(3): 317-25[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments